NCT02260895

Brief Summary

Diabetes is a major cause of morbidity and mortality worldwide. Prevention of diabetes is an important goal. The progression from impaired glucose tolerance to diabetes is thought to be promoted by the toxic effects of hyperglycemia on pancreatic beta cells. One of the main defects causing postprandial hyperglycemia in individuals with impaired glucose tolerance is reduced first phase (immediate) insulin release. The investigators hypothesis is that consuming a nutritional preload--a low-calorie, nutritionally balanced snack--30 minutes before ingesting a carbohydrate load, will moderate the hyperglycemic response to subsequent carbohydrate challenge and reduce glucotoxicity by stimulating insulin release and synthesis. The aim of this study is to test this hypothesis by comparing the standard 75-gram, two-hour oral glucose tolerance test (OGTT) response of 30 fasting adults who have impaired glucose tolerance to their OGTT response when the test is preceded by ½ ounce (14 grams) of dry-roasted, unsalted almonds. A pre-load interval of 30 minutes was chosen so that the peak of phase 2 (delayed) insulin response to the pre-load (45-60 minutes) would coincide with the timeframe of the steepest OGTT rise in glucose (15 to 30 minutes post challenge). The investigators hypothesize that the one-hour OGTT glucose level will be approximately 40 mg/dl lower when participants consume the pre-OGTT almond snack, compared to their one-hour glucose level on the standard two-hour OGTT. The two-hour OGTT glucose level is unlikely to show a statistically significant difference between the almond pre-test snack and control standard OGTT conditions.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2014

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 6, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 9, 2014

Completed
2 months until next milestone

Study Start

First participant enrolled

December 1, 2014

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2016

Completed
Last Updated

March 20, 2024

Status Verified

March 1, 2024

Enrollment Period

1.6 years

First QC Date

October 6, 2014

Last Update Submit

March 18, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • One-hour OGTT result

    One-hour oral glucose tolerance test result

    60 minutes into 2-hour oral glucose tolerance test

Secondary Outcomes (1)

  • Two-hour OGTT result

    120 minutes into 2-hour oral glucose tolerance test

Study Arms (2)

Control

NO INTERVENTION

Standard 2-hour 75-gram oral glucose tolerance test

Almond Pre-test snack

EXPERIMENTAL

1/2 ounce (14 g) almond snack 30 minutes prior to a 2-hour 75-gram oral glucose tolerance test

Dietary Supplement: Almond pre-test snack

Interventions

Almond pre-test snackDIETARY_SUPPLEMENT

unsalted, dry-roasted almonds, 1/2 oz (14 g), ingested 30 minutes prior to the start of a two-hour oral glucose tolerance test

Also known as: unsalted, dry-roasted almonds
Almond Pre-test snack

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • History of abnormal 1-hour OGTT result (\>160 mg/dL) or 2-hour OGTT (\>140)

You may not qualify if:

  • History of a diagnosis of diabetes
  • History of a 2-hour OGTT result \>200 mg/dL
  • History of a fasting glucose \>125 mg/dL

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Physicians at Sugar Creek - Memorial Family Medicine Residency Program

Sugar Land, Texas, 77478, United States

Location

MeSH Terms

Conditions

Prediabetic State

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Michael A Crouch, MD, MSPH

    Memorial Hermann Health System

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
AVP Research

Study Record Dates

First Submitted

October 6, 2014

First Posted

October 9, 2014

Study Start

December 1, 2014

Primary Completion

July 1, 2016

Study Completion

July 1, 2016

Last Updated

March 20, 2024

Record last verified: 2024-03

Locations